Publications by authors named "T Friberg"
Background: With the clinical advances in the field of gene therapy, the development of objective measures of visual function of patients with inherited retinal dystrophies (IRDs) is of utmost importance. Here, we propose one such measure.
Methods: We retrospectively analyzed data from a cohort of 194 eyes of 97 genetically diagnosed patients with retinitis pigmentosa (RP), the most common IRD, followed at the UPMC Vision Institute.
Challenges in posterior uveitis-tips and tricks for the retina specialist.
J Ophthalmic Inflamm Infect
August 2023
Article Synopsis
- Posterior uveitis is an eye condition that can affect anyone and is often a reason people visit eye doctors.
- It can be caused by infections, autoimmune diseases, and some conditions that look like uveitis but aren’t really it, which makes it tricky to diagnose.
- This study looked at different types of uveitis and their confusing similarities to other diseases to help doctors better recognize and treat these eye problems.
Objective: To identify characteristics and visual outcomes of coagulase-negative staphylococcal (CoNS) endophthalmitis in the era after the Endophthalmitis Vitrectomy Study.
Design: Single-centre retrospective analysis.
Participants: Forty-two samples from 40 patients with documented CoNS endophthalmitis.
Lidocaine Gel Interferes With the Antibacterial Activity of Povidone-Iodine.
Ophthalmic Surg Lasers Imaging Retina
July 2021
Background And Objective: Retina specialists use lidocaine gel as a topical anesthetic. We determined the antibacterial interaction between povidone-iodine (PI) and lidocaine gel using corneoscleral tissue as a solid phase medium.
Materials And Methods: Five pieces of corneoscleral tissue in five trials were inoculated with 1.
Purpose: To evaluate alterations in treatment burden and course of exudative age-related macular degeneration in patients who contracted endophthalmitis from intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections.
Methods: Retrospective study at the University of Pittsburgh Medical Center examining frequency of anti-VEGF injections, activity of choroidal neovascularization, and visual acuity before and after endophthalmitis treatment.
Results: Twenty-one patients meeting inclusion criteria were identified, of whom 7 (33%) patients did not restart anti-VEGF treatment 12 months after endophthalmitis because of quiescence of exudative age-related macular degeneration without significant visual acuity loss (P > 0.